Efficacy Data Cushion Tysabri, Burnt By Safety Scare

Biogen Idec weighs in on rumors of malignancies in trials of Tysabri rival cladribine.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet